Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-23-018561

Options or other derivatives

  • Chief Medical Officer acquired 66,620 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Morrow Phuong Khanh Chief Medical Officer 2023-03-10 Grant or award · Stock Option (Right to Buy) +44,620 44,620 D
Morrow Phuong Khanh Chief Medical Officer 2023-03-10 Grant or award · Restricted Stock Units +22,000 22,000 D
Loading xslF345X03/doc4.xml…